ATC Group: A03AB02 Glycopyrronium bromide

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A03AB02 in the ATC hierarchy

Level Code Title
1 A Alimentary tract and metabolism
2 A03 Drugs for functional gastrointestinal disorders
3 A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS
4 A03AB Synthetic anticholinergics, quaternary ammonium compounds
5 A03AB02 Glycopyrronium bromide

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 3 mg
PAREN - Parenteral 3 mg
RECTAL - Rectal 3 mg

Active ingredients in A03AB02

Active Ingredient Description
Glycopyrronium

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways.

Related product monographs

Title Information Source Document Type  
CUVPOSA Oral solution FDA, National Drug Code (US) MPI, US: SPL/PLR
ROBINUL Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
ROBINUL Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR
RYBRILA Oral solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
SIALANAR Oral solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicines in this ATC group

United States (US)

Austria (AT)

Canada (CA)

Estonia (EE)

Finland (FI)

Ireland (IE)

Lithuania (LT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Romania (RO)

South Africa (ZA)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.